Liminal BioSciences Inc. — key financial figures for fiscal year 2022 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2022)
- CA$401.0K
- Net Income/Loss (FY2022)
- CA$622.0K
- Total Assets (FY2022)
- CA$50.5M
- Total Equity (FY2022)
- CA$36.2M
- Cash Flows from Operating Activities (FY2022)
- -CA$31.8M
Source: Liminal BioSciences Inc. 20-F filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
